Results 91 to 100 of about 3,886,072 (310)

Identification of antibodies on microplates [PDF]

open access: yesImmunohematology, 1988
M N, Crawford   +3 more
openaire   +2 more sources

Identification of IgG antibody against CMV by BIE.

open access: yes, 2015
(A) Grayscale images of IgG antibody identification in serum; and (B) grayscale value and P-value of the IgG antibody identification. “*” indicates significant changes in grayscale values. In the first step, IgG was immobilized as ligand on the first and
Gang Jin (254417)   +8 more
core   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

Identification of antibody specificity using adsorption-elution studies with incompatible packed red cell unit

open access: yesAsian Journal of Transfusion Science
Antibody identification is usually performed by antibody identification panels which are specially selected red cells, at least one of which has a homozygous expression for all clinically significant blood group antigens facilitating agglutination upon ...
Kella Nivedita   +5 more
doaj   +1 more source

Early Diagnosis and Successful Treatment of Acute Antibody-Mediated Rejection of a Renal Transplant

open access: yes, 2011
Antibody-mediated rejection is a delicate situation. it rarely occurs but when it does, it usually results in graft dysfunction and frequently, graft loss.
YANG, YA-WEN;LIN, WEI-CHOU;WU, MING-SHIOU;LEE, PO-HUANG;TSAI, MENG-KUN   +1 more
core  

Antibody production in transgenic plants

open access: yes, 2022
S.301-318Antibodies bind with great affinity and specificity to their target antigens, allowing them to be exploited in research, medicine, agriculture, and industry.
Christou, P.   +4 more
core  

Unlocking the potential of cell‐permeable nanobodies for intracellular applications

open access: yesFEBS Letters, EarlyView.
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés   +2 more
wiley   +1 more source

Identification of Proliferating Keratinocytes in Middle Ear Cholesteatoma Using the Monoclonal Antibody Ki-67

open access: yes, 1996
Bujía J, Holly A, Sudhoff H, Antolí-Candela F, Tapia MG, Kastenbauer E. Identification of Proliferating Keratinocytes in Middle Ear Cholesteatoma Using the Monoclonal Antibody Ki-67. ORL.
Kastenbauer, Ernst   +11 more
core   +1 more source

How structural disorder and polyelectrolyte properties of prothymosin α enable its large interactome

open access: yesFEBS Letters, EarlyView.
In this review, complexes of the fully disordered and highly negatively charged prothymosin α are collected, described, and discussed. Linked to its poly‐electrostatic character, prothymosin α engages a large interactome through multiple different binding modes ranging from fully disordered complexes to short linear motif (SLiM)‐driven interactions ...
Ketty C. Tamburrini   +3 more
wiley   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

open access: yes, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
Matthew Buckland (589995)   +26 more
core   +2 more sources

Home - About - Disclaimer - Privacy